Biochip for K-ras mutation screening in ovarian cancer

被引：13

作者：

Fabjani, G

Kriegshaeuser, G

Schuetz, A

Prix, L

Zeillinger, R

机构：

[1] Med Univ Vienna, Dept Obstet & Gynecol, Div Gynecol, A-1090 Vienna, Austria

[2] Ludwig Boltzmann Inst Gynecol & Gynecol Oncol, Vienna, Austria

[3] ViennaLab Labordiagnost GmbH, Vienna, Austria

[4] Biofocus GmbH, Recklinghausen, Germany

来源：

CLINICAL CHEMISTRY | 2005年 / 51卷 / 04期

关键词：

D O I：

10.1373/clinchem.2004.041194

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：784 / 787

页数：4

共 21 条

[1]

Aunoble B, 2000, INT J ONCOL, V16, P567

[2]

BOS JL, 1989, CANCER RES, V49, P4682

[3] POINT MUTATION OF THE RAS ONCOGENE IN HUMAN OVARIAN-CANCER [J].

CHIEN, CH ;

CHOW, SN .

DNA AND CELL BIOLOGY, 1993, 12 (07) :623-627

[4]

Cuatrecasas M, 1998, CANCER-AM CANCER SOC, V82, P1088

[5]

Cuatrecasas M, 1997, CANCER, V79, P1581, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO

[6]

2-T

[7]

ENOMOTO T, 1991, AM J PATHOL, V139, P777

[8] ALTERATION OF THE P53 TUMOR-SUPPRESSOR GENE OCCURS INDEPENDENTLY OF K-RAS ACTIVATION AND MORE FREQUENTLY IN SEROUS ADENOCARCINOMAS THAN IN OTHER COMMON EPITHELIAL TUMORS OF THE HUMAN OVARY [J].

FUJITA, M ;

ENOMOTO, T ;

INOUE, M ;

TANIZAWA, O ;

OZAKI, M ;

RICE, JM ;

NOMURA, T .

JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (12) :1247-1256

[9]

FUKUMOTO M, 1989, CANCER RES, V49, P1693

[10] k-ras mutation may be an early event in mucinous ovarian tumorigenesis [J].

Garrett, AP ;

Lee, KR ;

Colitti, CR ;

Muto, MG ;

Berkowitz, RS ;

Mok, SC .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2001, 20 (03) :244-251

← 1 2 3 →